Anglo-French Drugs & Industries Limited - Company Profile

It is a pharma public limited company based in Bangalore North, Karnataka, India, established in 1923.

1923 Bangalore North, Karnataka, India Active

Last Updated: November 28, 2025

About Anglo-French Drugs & Industries Limited

Anglo-French Drugs & Industries Limited, a active public limited company, was established on 01 February 1923 in Bangalore North, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: L24230KA1923PLC010205. Registered under ROC Roc Bangalore. it is listed. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.13 Cr.

Formerly known as The Anglo-French Drug Company (Eastern) Limited. It upholds a compliant status. In 2023, it reported revenue of ₹110.10 Cr and a net worth of ₹208.84 Cr. Employing 252 professional, Its leadership includes Srinivasan Krishnan (Additional Director), Nirbhay Abhay Kanoria (Managing Director), Uddhav Abhay Kanoria (Managing Director). Past directors included Pauly Sukumar Nuthakki, Ashok Kumar Roy, Neha Rajen Gada. It holds ₹45.15 Cr open charges and ₹82.21 Cr settled loans. Its latest AGM occurred on 11 August 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.4, Phase Ii, Peenya Industrial Area, Peenya, Bangalore North, Karnataka, 560058.

Company Details

CIN/LLPIN
L24230MH1923PLC463682
Registration Number
010205
Incorporation Date
01 February 1923
Authorized Capital
₹2.00 Cr
Paid-Up Capital
₹1.13 Cr
ROC Code
Roc Bangalore
Listing Status
Listed
Company Status
Active

Key Metrics

Authorised Capital ₹ 2.00 Cr as on 28-11-2025
Paid Up Capital ₹ 1.13 Cr as on 28-11-2025
Company Age 103 Year, 27 Days
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 45.15 Cr as on 28-11-2025
Satisfied Charges ₹ 82.21 Cr as on 28-11-2025
Revenue Growth **** -33.52% (FY 2023)
Profit Growth **** 13068.28% (FY 2023)
Ebitda **** -606.36% (FY 2023)
Net Worth 1032.45% (FY 2023)
Total Assets **** 183.17% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Anglo-French Drugs & Industries Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Anglo-French Drugs & Industries Limited?

Current Directors

Name	Designation	Appointment Date	Status
Srinivasan Krishnan	Additional Director	12 Feb 2024	Current
Nirbhay Abhay Kanoria	Managing Director	01 Feb 2017	Current
Uddhav Abhay Kanoria	Managing Director	10 Aug 2006	Current
Rani Shokeen	Director	28 May 2024	Current
Pradeep Vasantrao Joshi	Additional Director	12 Feb 2024	Current
Abhay Kanoria	Director	01 Mar 1997	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Nominee Director	29 Jun 2018	Past
Pramod Abcsdd	Additional Director	24 Aug 2012	Past
Pramod Abcsdd	Additional Director	26 Sep 2016	Past
Pramod Abcsdd	Director	16 May 2008	Past
Pramod Abcsdd	Director	12 Aug 2024	Past
Pramod Abcsdd	Nominee Director	09 May 2023	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Anglo-French Drugs & Industries.

Anglo-French Drugs & Industries Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.52% decrease. The company also saw a substantial improvement in profitability, with a 13068.28% increase in profit. The company's net worth Soared by an impressive increase of 1032.45%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-33.52%

*******

Revenue from Operations

*******

-37.80%

*******

Total Assets

*******

183.17%

*******

Profit or Loss

*******

13068.28%

*******

Net Worth

*******

1032.45%

*******

EBITDA

*******

-606.36%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Anglo-French Drugs & Industries?

In 2022, Anglo-French Drugs & Industries had a promoter holding of 64.64% and a public holding of 35.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹451,549,000.00

Satisfied Charges

₹822,122,390.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 30.15 Cr
Standard Chartered Bank : 15.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
21 Apr 2025	Standard Chartered Bank	₹15.00 Cr	Open
11 Dec 2024	Hdfc Bank Limited	₹1.55 M	Open
12 Aug 2024	Hdfc Bank Limited	₹30.00 Cr	Open
18 Jul 2021	Hdfc Bank Limited	₹7.00 M	Satisfied
20 May 2021	Yes Bank Limited	₹1.20 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Anglo-French Drugs & Industries?

Anglo-French Drugs & Industries has a workforce of 252 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Anglo-French Drugs & Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anglo-French Drugs & Industries's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Anglo-French Drugs & Industries

Recent Activity within the Organization

Annual General Meeting

Progress on Anglo-French Drugs & Industries Limited last Annual general meeting of members was held on 11 Aug 2025 as per latest MCA records. was documented.
11 Aug 2025
Director Appointment

The activity Ganesh Ramgopalji Pallod was appointed as a Additional Director was appointed as a Additional Director on 11 Aug 2025 & has been associated with this company since 6 months 18 days . was completed.
11 Aug 2025
Charges

Progress on A charge registered on 07 Feb 2017 via Charge ID 100095424 with Yes Bank Limited was fully satisfied on 24 Jun 2025. was documented.
24 Jun 2025
Charges

Progress on A charge with Standard Chartered Bank amounted to Rs. 15.00 Cr with Charge ID 101088456 was registered on 21 Apr 2025. was documented.
21 Apr 2025
Balance Sheet

The activity Anglo-French Drugs & Industries Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.
31 Mar 2025
Charges

A charge registered on 23 Sep 2019 via Charge ID 100293428 with Axis Bank Limited was fully satisfied on 13 Jan 2025. was recorded as a recent event.
13 Jan 2025

Explore recent activity and updates - View Recent Activity